Statement Of Comprehensive Income [Abstract]

Pharming Group N.V. - Filing #2154299

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Statement of comprehensive income [abstract]
Profit (loss)	— USD	10,548,000 USD	10,548,000 USD	— USD	— USD	— USD	— USD	13,674,000 USD	— USD	13,674,000 USD
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) from investments in equity instruments	—	1,167,000 USD	—	—	—	—	—	705,000 USD	—	—
Other comprehensive income that will not be reclassified to profit or loss, net of tax	—	1,167,000 USD	—	—	—	—	—	705,000 USD	—	—
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	5,936,000 USD	—	—	—	—	—	10,349,000 USD	—	—
Other comprehensive income that will be reclassified to profit or loss, net of tax	—	5,936,000 USD	—	—	—	—	—	10,349,000 USD	—	—
Other comprehensive income	— USD	7,103,000 USD	— USD	— USD	7,103,000 USD	— USD	11,054,000 USD	11,054,000 USD	— USD	— USD
Comprehensive income	— USD	3,445,000 USD	10,548,000 USD	— USD	7,103,000 USD	— USD	11,054,000 USD	2,620,000 USD	— USD	13,674,000 USD